Home › Breast Cancer › NCT07389967
Nutrition Awareness Among Women With Non-Metastatic Breast Cancer
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: * Age \>18 -Female * Diagnosis of non-metastatic breast cancer * Completion of primary treatment for breast cancer * No recurrence or metastasis; or no other cancer other than basal or squamous cell * Willingness to provide a private email address for all study activities * Ability to read and understand English Exclusion Criteria: * Inability to comply with one or more of the inclusion criteria
About the study
This study explores perspectives of women with non-metastatic breast cancer regarding their willingness and ability to make dietary changes pertaining to foods/food products that may pose a risk to their cancer prognosis and survival.
This is a single-group study conducted entirely online. All study activities, including consent, educational brochure and surveys, will be completed remotely. Participants will receive email invitations to complete questionnaires in REDCap.
Questionnaire 1 will collect sociodemographic information (no PHI) and a brief dietary recall.
Questionnaire 2 will assess identification of ultra-processed foods. Before Questionnaire 3, participants will review a two-page educational flyer explaining the link between diet, obesity, and cancer, with information on unhealthy calories and food processing.
Questionnaire 3 will assess participants' willingness and ability to eat healthier foods and reduce unhealthy foods.
At study completion, participants will receive a thank-you message and a brief satisfaction survey.
What is being tested
- Educational Brochure (behavioral)
Sponsor: UNC Lineberger Comprehensive Cancer Center · Participants: 200 · Started: Jan 20, 2026
Contact the study team
- Allison Ross · Phone: 1 919-445-4905
Official record on ClinicalTrials.gov — NCT07389967
Locations in the U.S.
| North Carolina | UNC Cancer Hospital, Chapel Hill |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.